Risk of a post-colonoscopy colorectal cancer in patients with diverticular disease: a population-based cohort study

Abstract

Background Post-colonoscopy colorectal cancers (PCCRCs) may account for up to 30% of all colorectal cancers (CRCs) diagnosed in patients with diverticular disease; however, absolute and relative risks of PCCRC among these patients undergoing colonoscopy remain unknown.

Methods We performed a cohort study (1995–2015) including patients with and without diverticular disease who underwent colonoscopy. We calculated 7–36-month cumulative incidence proportions (CIPs) of PCCRC. We used Cox proportional hazards regression models to compute hazard ratios (HRs) of PCCRC, comparing patients with and without diverticular disease, as a measure of relative risk. We calculated 3-year PCCRC rates, as per World Endoscopy Organization recommendations, to estimate the proportion of CRC patients with and without diverticular disease who were considered to have PCCRC. We stratified all analyses by PCCRC location.

Results We observed 373 PCCRCs among 56 642 patients with diverticular disease and 1536 PCCRCs among 306 800 patients without diverticular disease. The PCCRC CIP after first-time colonoscopy was 0.45% (95%CI 0.40%–0.51%) for patients with and 0.36% (95%CI 0.34%–0.38%) for patients without diverticular disease. Comparing patients with and without diverticular disease undergoing first-time colonoscopy, the adjusted HR was 0.84 (95%CI 0.73–0.97) for PCCRC and 1.23 (95%CI 1.01–1.50) for proximal PCCRCs. The 3-year PCCRC rate was 19.0% (22.3% for proximal PCCRCs) for patients with and 6.5% for patients without diverticular disease.

Conclusions Although the absolute risk was low, the relative risk of proximal PCCRCs may be elevated in patients with diverticular disease undergoing colonoscopy compared with patients without the disease.

Publication History

Received: 13 July 2023

Accepted after revision: 08 February 2024

Accepted Manuscript online:
08 February 2024

Article published online:
13 March 2024

• References

• 1 Stoffel EM, Erichsen R, Froslev T. et al. Clinical and molecular characteristics of post-colonoscopy colorectal cancer: a population-based study. Gastroenterology 2016; 151: 870-878.e873
• 2 Morris EJ, Rutter MD, Finan PJ. et al. Post-colonoscopy colorectal cancer (PCCRC) rates vary considerably depending on the method used to calculate them: a retrospective observational population-based study of PCCRC in the English National Health Service. Gut 2015; 64: 1248-1256
• 3 Pedersen L, Valori R, Bernstein I. et al. Risk of post-colonoscopy colorectal cancer in Denmark: time trends and comparison with Sweden and the English National Health Service. Endoscopy 2019; 51: 733-741
• 4 Macken E, Van Dongen S, De I Brabander. et al. Post-colonoscopy colorectal cancer in Belgium: characteristics and influencing factors. Endosc Int Open 2019; 7: E717-e727 DOI: 10.1055/a-0751-2660. (PMID: 31073539)
• 5 Burr NE, Derbyshire E, Taylor J. et al. Variation in post-colonoscopy colorectal cancer across colonoscopy providers in English National Health Service: population based cohort study. BMJ 2019; 367: l6090 DOI: 10.1136/bmj.l6090. (PMID: 31722875)
• 6 Forsberg A, Hammar U, Ekbom A. et al. Post-colonoscopy colorectal cancers in Sweden: room for quality improvement. Eur J Gastroenterol Hepatol 2017; 29: 855-860 DOI: 10.1097/MEG.0000000000000884. (PMID: 28410353)
• 7 Erichsen R, Baron JA, Stoffel EM. et al. Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study. Am J Gastroenterol 2013; 108: 1332-1340 DOI: 10.1038/ajg.2013.175. (PMID: 23774154)
• 8 Troelsen FS, Sørensen HT, Pedersen L. et al. Risk of a post-colonoscopy colorectal cancer in patients with type 2 diabetes: a Danish population-based cohort study. BMJ Open Gastroenterol 2021; 8: e000786
• 9 Schønfeldt Troelsen F, Sørensen HT, Pedersen L. et al. Risk of a post-colonoscopy colorectal cancer diagnosis in patients with inflammatory bowel disease: a population-based cohort study. Endoscopy 2021; 53: 1023-1033
• 10 Subramaniam K, Ang PW, Neeman T. et al. Post-colonoscopy colorectal cancers identified by probabilistic and deterministic linkage: results in an Australian prospective cohort. BMJ open 2019; 9: e026138 DOI: 10.1136/bmjopen-2018-026138. (PMID: 31230004)
• 11 Peery AF, Crockett SD, Murphy CC. et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology 2019; 156: 254-272.e211
• 12 Willington AJ, Cosgrove S, Davison P. et al. Prevalence and characteristics of post-colonoscopy colorectal cancers in a New Zealand regional centre: a 10-year analysis. Int Med J 2021; 51: 249-253 DOI: 10.1111/imj.14811. (PMID: 32115815)
• 13 Cooper GS, Xu F, Schluchter MD. et al. Diverticulosis and the risk of interval colorectal cancer. Dig Dis Sci 2014; 59: 2765-2772 DOI: 10.1007/s10620-014-3246-8. (PMID: 24927800)
• 14 Schmidt M, Schmidt SAJ, Adelborg K. et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol 2019; 11: 563-591
• 15 Njor SH, Friis-Hansen L, Andersen B. et al. Three years of colorectal cancer screening in Denmark. Cancer Epidemiol 2018; 57: 39-44 DOI: 10.1016/j.canep.2018.09.003. (PMID: 30292899)
• 16 Pedersen CB. The Danish Civil Registration System. Scand J Public Health 2011; 39: 22-25 DOI: 10.1007/s10654-014-9930-3. (PMID: 24965263)
• 17 Schmidt M, Schmidt SA, Sandegaard JL. et al. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 2015; 7: 449-490 DOI: 10.2147/CLEP.S91125. (PMID: 26604824)
• 18 Erichsen R, Baron JA, Hamilton-Dutoit SJ. et al. Increased risk of colorectal cancer development among patients with serrated polyps. Gastroenterology 2016; 150: 895-902.e895
• 19 Erichsen R, Strate L, Sorensen HT. et al. Positive predictive values of the International Classification of Disease, 10th edition diagnoses codes for diverticular disease in the Danish National Registry of Patients. Clin Exp Gastroenterol 2010; 3: 139-142 DOI: 10.2147/CEG.S13293. (PMID: 21694857)
• 20 Rutter MD, Beintaris I, Valori R. et al. World Endoscopy Organization consensus statements on post-colonoscopy and post-imaging colorectal cancer. Gastroenterology 2018; 155: 909-925.e903
• 21 Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health 2011; 39: 42-45 DOI: 10.1177/1403494810393562. (PMID: 21775350)
• 22 Thygesen SK, Christiansen CF, Christensen S. et al. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 2011; 11: 83 DOI: 10.1186/1471-2288-11-83. (PMID: 21619668)
• 23 Aalen OO, Johansen S. An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scand J Statist 1978; 5: 141-150
• 24 Rivero-Sánchez L, Grau J, Augé JM. et al. Colorectal cancer after negative colonoscopy in fecal immunochemical test-positive participants from a colorectal cancer screening program. Endosc Int Open 2018; 6: E1140-e1148
• 25 Carballal S, Sánchez A, Moreira L. et al. Prevalence of adenomatous polyposis in a fecal immunochemical test-based colorectal cancer screening program and risk of advanced neoplasia during follow-up. Endoscopy 2022; 54: 688-697
• 26 Nielsen JC, Ploug M, Baatrup G. et al. Risk of post colonoscopy colorectal cancer following screening colonoscopy with low-risk or no adenomas: a population-based study. Colorectal Dis 2021; 23: 2932-2936 DOI: 10.1111/codi.15966. (PMID: 34751486)
• 27 Anderson R, Burr NE, Valori R. Causes of post-colonoscopy colorectal cancers based on World Endoscopy Organization system of analysis. Gastroenterology 2020; 158: 1287-1299.e2 DOI: 10.1053/j.gastro.2019.12.031. (PMID: 31926170)
• 28 Beaton D, Beintaris I, Rutter MD. Utilization and reproducibility of World Endoscopy Organization post-colonoscopy colorectal cancer algorithms: retrospective analysis. Endoscopy 2022; 54: 270-277 DOI: 10.1055/a-1409-5531. (PMID: 33682892)
• 29 Ahmad A, Dhillon A, Saunders BP. et al. Validation of post-colonoscopy colorectal cancer (PCCRC) cases reported at national level following local root cause analysis: REFLECT study. Frontline Gastroenterol 2022; 13: 374-380 DOI: 10.1136/flgastro-2021-102016. (PMID: 36051952)
• 30 Aerts R, Severi C, Van Roey G. et al. A single-centre analysis of post-colonoscopy colorectal cancer. Acta Gastroenterol Belg 2021; 84: 401-405 DOI: 10.51821/84.3.003. (PMID: 34599562)
• 31 Bogie RMM, le Clercq CMC, Voorham QJM. et al. Molecular pathways in post-colonoscopy versus detected colorectal cancers: results from a nested case-control study. Br J Cancer 2022; 126: 865-873
• 32 Samadder NJ, Curtin K, Tuohy TM. et al. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study. Gastroenterology 2014; 146: 950-960 DOI: 10.1053/j.gastro.2014.01.013. (PMID: 24417818)
• 33 Samadder NJ, Neklason D, Snow A. et al. Clinical and molecular features of post-colonoscopy colorectal cancers. Clin Gastroenterol Hepatol 2019; 17: 2731-2739.e2732
• 34 ley DA, Jensen CD, Marks AR. et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 2014; 370: 1298-1306 DOI: 10.1056/NEJMoa1309086. (PMID: 24693890)
• 35 van Toledo D, JEG IJ, Bossuyt PMM. et al. Serrated polyp detection and risk of interval post-colonoscopy colorectal cancer: a population-based study. Lancet Gastroenterol Hepatol 2022; 7: 747-754 DOI: 10.1016/S2468-1253(22)00090-5. (PMID: 35550250)